Literature DB >> 16555973

Fibulin-5 function during tumorigenesis.

Allan R Albig1, William P Schiemann.   

Abstract

Tumorigenesis is the process by which normal cells evolve the capacity to evade and overcome the constraints normally placed upon their growth and survival. During cancer progression, indolent tumors experience an array of genetic and epigenetic events that ultimately coordinate the development of tumor metastasis, which is the most lethal facet of cancer and the leading cause of cancer-related death. The therapeutic necessity to combat tumor metastasis continues to drive investigations aimed at identifying novel regulators of this deadly process. Fibulin-5 is a newly described extracellular matrix protein that is important for normal embryonic development and organogenesis. Fibulin-5 expression may also be associated with the suppression of tumor formation through its control of cell proliferation, motility and angiogenic sprouting. Here, the tumor suppressing activities of fibulin-5 are reviewed, and the potential use and targeting of fibulin-5 to combat growth and metastasis of human malignancies is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16555973     DOI: 10.1517/14796694.1.1.23

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  23 in total

1.  Expression, purification, and characterization of recombinant fibulin-5 in a prokaryote expression system.

Authors:  Myoung Seok Jeong; Chang Soo Kang; Yeon Soo Han; In Seok Bang
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 3.  Role of TGF-β and the tumor microenvironment during mammary tumorigenesis.

Authors:  Molly A Taylor; Yong-Hun Lee; William P Schiemann
Journal:  Gene Expr       Date:  2011

4.  The bone marrow-derived human mesenchymal stem cell: potential progenitor of the endometrial stromal fibroblast.

Authors:  Lusine Aghajanova; Jose A Horcajadas; Francisco J Esteban; Linda C Giudice
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

5.  Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible factor-1 (HIF-1α)-dependent mechanism.

Authors:  Anna Guadall; Mar Orriols; Ricardo Rodríguez-Calvo; Olivier Calvayrac; Javier Crespo; Rosa Aledo; José Martínez-González; Cristina Rodríguez
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

6.  Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.

Authors:  Mary Topalovski; Michelle Hagopian; Miao Wang; Rolf A Brekken
Journal:  J Biol Chem       Date:  2016-08-16       Impact factor: 5.157

7.  Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.

Authors:  Jia-Cheng Tang; Jing-Hua Liu; Xiao-Long Liu; Xiao Liang; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation.

Authors:  Amy Louise Winship; Kate Rainczuk; Amanda Ton; Eva Dimitriadis
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

9.  Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.

Authors:  Wen Yue; Quanhong Sun; Rodney Landreneau; Chuanyue Wu; Jill M Siegfried; Jian Yu; Lin Zhang
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

10.  Fibulin-5, an integrin-binding matricellular protein: its function in development and disease.

Authors:  Hiromi Yanagisawa; Marie K Schluterman; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.